Moreover, TGF-β, whose activity is increased in systemic sclerosis, favored the expansion of KLRG1− ILC2s while simultaneously decreasing their production of IL-10 in the skin of systemic sclerosis patients and increasing myofibroblast differentiation (206). This evidence concerns the gene IL10 and systemic sclerosis.